Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017168 (
gastroesophageal reflux disease
)
11,783
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The relationship between
gastroesophageal reflux
and asthma has not been clearly defined. We measured the lower esophageal sphincter pressures and studied
gastroesophageal reflux
patterns over 24 hours using an ambulatory Gastroreflux Recorder (
Del
Mar Avionics, Irvine, CA) in 44 controls and 104 consecutive adult asthmatics. The presence or absence of reflux symptoms was not used as a selection criterion for asthmatics. All asthmatics had discrete episodes of diffuse wheezing and documented reversible airway obstruction of at least 20%. Patients underwent reflux testing while receiving, if any, their usual asthmatic medications: 71.2% required chronic bronchodilators and 28.8% required no bronchodilators. Compared with controls, asthmatics had significantly decreased lower esophageal sphincter pressures, greater esophageal acid exposure times, more frequent reflux episodes, and longer clearance times in both the upright and supine positions (P less than 0.0001 for all parameters tested). There were no differences in any of the measured reflux parameters between asthmatics who required bronchodilators and those who did not. Thus, the decreased lower esophageal sphincter pressures and increased levels of acid reflux in asthmatics were not entirely caused by the effects of bronchodilator therapy. Receiver-operating characteristic analysis generated reflux values that discriminated asthmatics from controls. More than 80% of adult asthmatics have abnormal
gastroesophageal reflux
. We conclude that most adult asthmatics, regardless of the use of bronchodilator therapy, have abnormal
gastroesophageal reflux
manifested by increased reflux frequency, delayed acid clearance during the day and night, and diminished lower esophageal sphincter pressures.
...
PMID:Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. 186 Jun 56
It is now widely recognized that
gastroesophageal reflux
(
GER
) causes many symptoms in infants and children; however, the implication of a causal relationship between
GER
and pulmonary disease still raises skepticism in many clinicians. Recurrent or chronic pulmonary disease (CPD) is a significant cause for morbidity and mortality in infants and children. There is no single, reliable, diagnostic test that consistently demonstrates that pulmonary symptoms are caused directly by
GER
. This contributes to lack of firm association between
GER
and CPD. Is
GER
a contributory factor to the severity of the pulmonary disease, as in chronic asthma? Is it the primary cause of all the respiratory pathophysiology? Or, is
GER
the result of altered pulmonary mechanics? These are questions that remain unanswered. The purpose of this article is to review the literature raising skepticism among clinicians, paving the way for future directions of research.
Del
Med J 1989 Oct
PMID:Gastroesophageal reflux and recurrent/chronic pulmonary disease in infants and children. 269 Dec 87
Del
(22q11) is a common microdeletion syndrome with an extremely variable phenotype. Besides classical manifestations, such as velocardiofacial (Shprintzen) or DiGeorge syndromes, del(22q11) syndrome may be associated with unusual but probably causally related anomalies that expand its phenotype and complicate its recognition. We report here three children with the deletion and a chronic, erosive polyarthritis resembling idiopathic cases of juvenile rheumatoid arthritis (JRA). Patient 1, born in 1983, initially presented with developmental delay, facial dysmorphism, velopharyngeal insufficiency, and severe gastro-
oesophageal reflux
requiring G tube feeding. From the age of 3 years, he developed JRA, which resulted in severe restrictive joint disease, osteopenia, and platyspondyly. Patient 2, born in 1976, had tetralogy of Fallot and peripheral pulmonary artery stenosis. She developed slowly, had mild dysmorphic facial features, an abnormal voice, and borderline intelligence. JRA was diagnosed at the age of 5 years. The disorder followed a subacute course, with relatively mild inflammatory phenomena, but an extremely severe skeletal involvement with major osteopenia, restrictive joint disease (bilateral hip replacement), and almost complete osteolysis of the carpal and tarsal bones with phalangeal synostoses, leading to major motor impairment and confinement to a wheelchair. Patient 3, born in 1990, has VSD, right embryo-toxon, bifid uvula, and facial dysmorphism. She developed JRA at the age of 1 year. She is not mentally retarded but has major speech delay secondary to congenital deafness inherited from her mother. In the three patients, a del(22q11) was shown by FISH analysis. These observations, and five other recently published cases, indicate that a JRA-like syndrome is a component of the del(22q11) spectrum. The deletion may be overlooked in those children with severe, chronic inflammatory disorder.
...
PMID:Juvenile rheumatoid arthritis and del(22q11) syndrome: a non-random association. 983 43
With combined pH and impedance monitoring, non-acid, as well as acid reflux episodes, are more commonly detected immediately prior to cough in asthma in children.
Gastroesophageal reflux
should be evaluated as a trigger for cough in difficult childhood asthma.
Del
Med J 2014 May
PMID:Cough in asthma triggered by reflux episodes. 2508 Jun 57